NDC 0480-3631

Pitavastatin 1.045 mg tablet, film coated

On the label: Teva Pharmaceuticals, Inc..

Where it's made

Recalls

• Jun 11, 2025 · Class III · Orient Pharma Co., Ltd. Yunlin Plant
  Failed Impurities/Degradation Specifications.
  Lots: P061001, P061002, P061003, P061004, P061006 & P061007 Exp Date 07/2025; P061008, Exp Date 08/2025; P061009 & P061010 Exp Date 10/2025; P061011, P061012 & P061013 Exp Date 01/2026; P061016, P061017 & P061018, Exp Date 04/2026; P061019, Exp Date 05/2026; P061023, Exp Date 01/2027.
• Jun 11, 2025 · Class III · Orient Pharma Co., Ltd. Yunlin Plant
  Failed Impurities/Degradation Specifications.
  Lots: P051001, P051002, & P051003, Exp Date 07/2025; P051005, Exp Date 10/2025; P051006, Exp Date 10/2025; P051007, Exp Date 01/2026; P051010, Exp Date 07/2026; P051011 & P051012, Exp Date 09/2026; P051013, P051014 and P051015, Exp Date 01/2027.

Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.

Product details

Generic drug

Pitavastatin: every company that makes it

Form

tablet, film coated, oral

Strength

1.045 mg

Approval

ANDA ANDA205932

On the market since

Nov 2, 2023

Package NDCs

0480-3631-98

Official label

DailyMed (National Library of Medicine), updated May 23, 2024

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?